The acquisition strategically shifts IPG toward higher-margin medical markets and is funded from cash, avoiding dilution. Watch for completion of the French works council consultation and FDI clearance as the next catalysts. The earnout structure incentivizes Lumibird Medical's 2026-2027 performance, so monitor those metrics. The deal is expected to close in Q4 2026.
Price Chart
Executive Summary
IPG Photonics entered a binding put option agreement to acquire Lumibird Medical, a medical laser business, for €300M in cash (plus up to €50M earnout), funded from cash on hand. The acquisition expands IPG's medical laser platform into ophthalmology, adding ~$1B in addressable market, and is expected to be accretive to gross margin, EBITDA, and adjusted EPS. Closing is expected in Q4 2026, subject to French works council consultation and foreign direct investment approval.
Key Financial Metrics
Key Facts
- Purchase price of €300M on a cash-free, debt-free basis, payable in cash at closing
- Contingent earnout of up to €50M additional cash based on 2026 and 2027 performance metrics
- Lumibird Medical reported FY2025 revenue of €112.2M and EBITDA of €24.1M (21.5% margin)
- Acquisition funded entirely from IPG's cash on hand — no debt or equity issuance
- Expected to close in Q4 2026, subject to French FDI authorization and works council consultation
- Break-up fee of €3.5M payable by seller if put option is not exercised after consultation completes
Financial Impact
€300M (~$349M) base purchase price plus up to €50M earnout; target has €112.2M revenue and 21.5% EBITDA margin; deal represents ~8% of IPGP's $4.4B market cap
Risk Factors
- French foreign direct investment approval may be delayed or denied
- Integration of Lumibird Medical's operations and culture could underperform expectations
- Earnout targets may not be achieved, reducing total deal value and signaling weaker performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001111928-26-000142 |
| Document: ipgp-20260716.htm | 0001111928-26-000142 |
| Document: ipgpacquisitionoflumibirdm.htm | 0001111928-26-000142 |
| Document: ipgpacquisitionoflumibir.htm | 0001111928-26-000142 |
| Document: 0001111928-26-000142-index-headers.html | 0001111928-26-000142 |
| Document: 0001111928-26-000142-index.html | 0001111928-26-000142 |
| Document: 0001111928-26-000142.txt | 0001111928-26-000142 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Institutional Cluster | $73.76 | awaiting T+20 | — | $72.81 (−1.29%) |
Sep 23, 2026 4w ago | Court Ruling | $77.42 $69.41 | ▲ +10.35% | ▲ +9.93% | $72.81 (+5.95%) |
Sep 3, 2026 7w ago | Insider Cluster | $78.00 $83.60 | ▲ +7.18% | ▲ +6.33% | $72.81 (−6.65%) |
Aug 6, 2026 11w ago | Insider Cluster | $90.23 $78.00 | ▼ −13.55% | ▼ −13.16% | $72.81 (−19.31%) |
Aug 4, 2026 11w ago | Insider Cluster | $91.75 $76.48 | ▼ −16.64% | ▼ −16.04% | $72.81 (−20.64%) |
Aug 4, 2026 11w ago | 8-K | $94.07 $75.20 | ▼ −20.06% | ▼ −18.82% | $72.81 (−22.60%) |
Jul 17, 2026 14w ago | 8-K | $104.33 $85.79 | ▼ −17.77% | ▼ −22.22% | $72.81 (−30.21%) |
Jul 16, 2026 14w ago | Press Release | $104.33 $85.79 | ▼ −17.77% | ▼ −22.22% | $72.81 (−30.21%) |
Jul 1, 2026 16w ago | Insider Cluster | $105.27 $85.06 | ▼ −19.20% | ▼ −19.50% | $72.81 (−30.83%) |
Jun 11, 2026 19w ago | Institutional Cluster | $111.19 $108.03 | ▼ −2.84% | ▼ −4.73% | $72.81 (−34.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers